Atlas FDA

ev3 Protege Rx Tapered Carotid Stent System, SECX-10-7-40-135, Sterile EO, Rx only. Indicated for the treatment of patie

FDA device recall Z-0878-2015 · posted 2014-12-29 · Terminated

Recall details

Recalling firm
Ev3, Inc.
Reason for recall
Two production lots of the Protege Rx Tapered Carotid Stent Systems (SECX-10-7-40-135, Lot # 9922452 & SEPX-8-6-40-135, Lot # 9922795) because of a product labeling error.
Action taken
Consignees were sent on 12/4/2014 a Covidien "Urgent Field Safety Notice" letter dated 4th December 2014. The letter described the problem and the product involved in the recall. Advised consignees to quarantine, discontinue use of the device and return the product to Covidien. They also requested consignees to complete the "Recall Verification Form" and return it to Covidien. For questions, customers can contact their local Covidien Representative.
Root cause
Packaging process control
Status
Terminated
Product code
NIM
Quantity affected
14
Distribution
International Only Distribution -- RUSSIA, ROMANIA, UNITED KINGDOM, GERMANY, ITALY, SPAIN, FRANCE, TURKEY, POLAND, and JAPAN.
Date initiated
2014-12-04
Date posted
2014-12-29
Date terminated
2015-07-17
Location
Plymouth, MN

Monitor recalls programmatically

Recalls and clearances share one API, with change alerts when new recalls post.